MedPath

Effect of L - carnitine on oxidative stress markers in patients with Hyperlipidemia

Phase 2
Conditions
Hyperlipidaemia.
Hyperlipidaemia, unspecified
Registration Number
IRCT2014011416214N1
Lead Sponsor
Vice chancellor for research, Baqiyatallah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Incidence of Hyperlipidemia with Cholesterol levels = 200 mg /dL or Triglycerides levels = 200 mg /dL) or LDL = 130; Age range between 18 and 65 years; Both groups of males and females; Patients do not use Hypolipidemia drugs in 2 month ago.
Exclusion criteria: Hypothyroidism disease; Acute Coronary Disease; Renal disease; Pregnancy; Usage of drugs and alcohol; Inflammatory disease; Chronic Liver Disease (Cirrhosis, Hepatitis, etc.); Anti-seizure drugs; Consumption of antioxidant supplements.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Total Antioxidant Capacity. Timepoint: Before and after Intervention. Method of measurement: ELISA.;Serum Malondialdehyde. Timepoint: Before and after Intervention. Method of measurement: Colorimetric.;GSH. Timepoint: Before and after Intervention. Method of measurement: Colorimetric.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath